Cargando…
Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial
PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gyneco...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442518/ https://www.ncbi.nlm.nih.gov/pubmed/34524631 http://dx.doi.org/10.1007/s11764-021-01081-z |
_version_ | 1783753023722356736 |
---|---|
author | Knoerl, Robert Giobbie-Hurder, Anita Berfield, Juliana Berry, Donna Meyerhardt, Jeffrey A. Wright, Alexi A. Ligibel, Jennifer A. |
author_facet | Knoerl, Robert Giobbie-Hurder, Anita Berfield, Juliana Berry, Donna Meyerhardt, Jeffrey A. Wright, Alexi A. Ligibel, Jennifer A. |
author_sort | Knoerl, Robert |
collection | PubMed |
description | PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gynecological oncology centers at Dana-Farber Cancer Institute. Participants were randomized (2:1) to receive an 8-week yoga intervention or usual care. After 21/50 of participants were enrolled, the COVID-19 pandemic required the yoga intervention to be delivered virtually (i.e., Zoom). Pre- and post-intervention, participants self-reported CIPN and co-occurring symptom severity. Adherence to the intervention was defined as practicing ≥ 12 yoga sessions over the 8-week intervention period. Changes in patient-reported outcomes between groups were compared using Wilcoxon’s rank-sum tests. RESULTS: Participants (n = 28 yoga, n = 16 control) were mainly female (96%) and diagnosed with stage III/IV disease (66%). Overall, 19/28 (67.8%) of yoga group participants were adherent to the yoga protocol. Yoga group participants experienced significant within-group improvements in all patient-reported outcomes, including worst CIPN pain (median change = − 1.7, p < 0.0001) and sensory CIPN (median change = − 14.8, p < 0.0001), but only improvements in fatigue (p = 0.05) and depression (p = 0.04) were significant compared to the control. There were no differences (p > 0.05) in changes in patient-reported outcomes between in-person (n = 6) or virtual (n = 15) yoga group participants. CONCLUSIONS: Yoga is a feasible non-pharmacological modality for cancer survivors with CIPN, but more information is needed regarding its impact on CIPN and other symptoms. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03824860 IMPLICATIONS FOR CANCER SURVIVORS: Oncology clinicians may consider referring cancer survivors to yoga for chronic CIPN pain, but yoga cannot be currently recommended as an efficacious treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-021-01081-z. |
format | Online Article Text |
id | pubmed-8442518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-84425182021-09-15 Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial Knoerl, Robert Giobbie-Hurder, Anita Berfield, Juliana Berry, Donna Meyerhardt, Jeffrey A. Wright, Alexi A. Ligibel, Jennifer A. J Cancer Surviv Article PURPOSE: To determine the feasibility of implementing a yoga intervention for cancer survivors with chronic CIPN pain, as well as the impact of the intervention on patient-reported outcomes. METHODS: Cancer survivors with chronic CIPN pain were recruited from the breast, gastrointestinal, and gynecological oncology centers at Dana-Farber Cancer Institute. Participants were randomized (2:1) to receive an 8-week yoga intervention or usual care. After 21/50 of participants were enrolled, the COVID-19 pandemic required the yoga intervention to be delivered virtually (i.e., Zoom). Pre- and post-intervention, participants self-reported CIPN and co-occurring symptom severity. Adherence to the intervention was defined as practicing ≥ 12 yoga sessions over the 8-week intervention period. Changes in patient-reported outcomes between groups were compared using Wilcoxon’s rank-sum tests. RESULTS: Participants (n = 28 yoga, n = 16 control) were mainly female (96%) and diagnosed with stage III/IV disease (66%). Overall, 19/28 (67.8%) of yoga group participants were adherent to the yoga protocol. Yoga group participants experienced significant within-group improvements in all patient-reported outcomes, including worst CIPN pain (median change = − 1.7, p < 0.0001) and sensory CIPN (median change = − 14.8, p < 0.0001), but only improvements in fatigue (p = 0.05) and depression (p = 0.04) were significant compared to the control. There were no differences (p > 0.05) in changes in patient-reported outcomes between in-person (n = 6) or virtual (n = 15) yoga group participants. CONCLUSIONS: Yoga is a feasible non-pharmacological modality for cancer survivors with CIPN, but more information is needed regarding its impact on CIPN and other symptoms. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03824860 IMPLICATIONS FOR CANCER SURVIVORS: Oncology clinicians may consider referring cancer survivors to yoga for chronic CIPN pain, but yoga cannot be currently recommended as an efficacious treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11764-021-01081-z. Springer US 2021-09-15 2022 /pmc/articles/PMC8442518/ /pubmed/34524631 http://dx.doi.org/10.1007/s11764-021-01081-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Knoerl, Robert Giobbie-Hurder, Anita Berfield, Juliana Berry, Donna Meyerhardt, Jeffrey A. Wright, Alexi A. Ligibel, Jennifer A. Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title | Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title_full | Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title_fullStr | Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title_full_unstemmed | Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title_short | Yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
title_sort | yoga for chronic chemotherapy-induced peripheral neuropathy pain: a pilot, randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442518/ https://www.ncbi.nlm.nih.gov/pubmed/34524631 http://dx.doi.org/10.1007/s11764-021-01081-z |
work_keys_str_mv | AT knoerlrobert yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT giobbiehurderanita yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT berfieldjuliana yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT berrydonna yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT meyerhardtjeffreya yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT wrightalexia yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial AT ligibeljennifera yogaforchronicchemotherapyinducedperipheralneuropathypainapilotrandomizedcontrolledtrial |